Peptides are highly effective and selective signaling molecules that bind to certain cell surface receptors, such as ion channels and G protein-coupled receptors (GPCRs), to cause intracellular effects. They are used in the pharmaceutical sector to create innovative regenerative treatments that can target and modulate a broad spectrum of cells. These therapies are less toxic, safer, and better tolerated than other therapy choices. Peptide therapeutics market growth is driven by the increased incidence of infectious diseases, cancer, and metabolic disorders such as obesity, diabetes, and osteoporosis, together with rising demand for effective medications.
A Comprehensive Market Analysis
DataM Intelligence’s report on the peptide therapeutics market provides insightful analysis of the latest trends and developments in the market. It outlines the current market dynamics and provides detailed insights into the market growth, revenue opportunities, and key players. Our report provides an accurate assessment of the peptide therapeutics market market size and opportunities and explores the potential impact of the latest trends and developments.
Market Drivers
The Increasing Prevalence of Cancer and Metabolic Disorders Will Drive the Market Growth
The growing frequency of cancer and metabolic diseases, increased expenditures in research and development of innovative medications, and technical improvements in peptide therapies are the primary drivers driving market expansion.
Chronic illnesses, such as cancer, cardiovascular disease, and diabetes, are the major causes of death and disability globally, according to the World Health Organization (WHO). Chronic disease rates are increasing internationally, moving across all regions and affecting all socioeconomic strata.
Market Trends
Cancer has become one of the world's top causes of death. According to the GLOBOCAN study, 19.3 million new instances of cancer were detected in 2020, with 10 million individuals dying as a result of cancer. According to the GLOBOCAN study, this figure will rise to 28.4 million cancer cases worldwide by 2040.
Peptide therapies have emerged as an exciting new therapy option for solid tumors such as breast cancer. Researchers have been working on creating innovative and effective peptide therapies for numerous illnesses, including cancer, due to the benefits of peptide therapeutics, such as simplicity of synthesis, high target specificity and selectivity, and low toxicity.
Market Key Players
The research study includes profiles of leading companies operating in the peptide therapeutics market:
- Eli Lilly and Company
- Amgen Inc., Pfizer Inc.
- Bristol-Myers Squibb Company
To Know More Download Sample
